Delivery Order SPE2DB24D2205-SPE2DB25FEHAD
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,439.29 to AmerisourceBergen Drug Corp for Mounjaro 5 mg/0.5 mL pen injectors with a completion date of July 29, 2025. This firm fixed-price delivery order, issued on July 28, 2025, represents a competitively awarded contract with no set-aside designation. The product will be supplied from AmerisourceBergen's location in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $13,780.15 to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 mL pen injectors on July 21, 2025, with completion targeted for July 22, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- The Defense Logistics Agency awarded a delivery order valued at $2,123.03 to AmerisourceBergen Drug Corp for Mounjaro 10 mg/0.5 ml pen injectors on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed price delivery order, issued without a set-aside designation, represents a competitively awarded pharmaceutical supply transaction supporting federal medical procurement needs. The product will be delivered to AmerisourceBergen's facility in Conshohocken,...
- The Defense Logistics Agency awarded a $4,353.44 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Mounjaro 10 mg/0.5 mL pen injectors. This is a non-set-aside, competitively awarded contract with an ultimate completion date of August 12, 2025, and performance to be executed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order represents a single transaction under a larger indefinite delivery vehicle that enables DLA to...
- The Defense Logistics Agency awarded a delivery order valued at $2,176.72 to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 mL pen injectors on August 27, 2025, with an ultimate completion date of August 28, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively to the prime contractor's corporate office located in Conshohocken, Pennsylvania. The contract represents a single transaction under AmerisourceBergen's broader...
- The Defense Logistics Agency awarded a delivery order valued at $1,647.57 to AmerisourceBergen Drug Corp for the supply of Mounjaro 10 mg/0.5 ml pen injectors (0.5 ml). This firm fixed-price delivery order, issued on August 8, 2025, with an ultimate completion date of August 11, 2025, represents a non-competitive award under the company's existing indefinite delivery contract. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro 15 mg/0.5 ml pen injections, with a contract value of $6,577.97 and a completion date of August 1, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and was issued on July 31, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance for this order, which falls under the company's existing...
- The Defense Logistics Agency awarded a $4,719.27 delivery order to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 ml pen injectors on August 1, 2025, with an ultimate completion date of August 4, 2025. This non-set-aside, firm fixed price delivery order represents a routine pharmaceutical procurement to support federal medical supply needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for...
- The Defense Logistics Agency awarded a delivery order valued at $9,379.27 to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 ml pens on August 18, 2025, with completion scheduled for August 19, 2025. This firm fixed price delivery order is issued without set-aside status, indicating competitive award based on open competition. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $10,431.03 delivery order on July 25, 2025, for Mounjaro 12.5 mg/0.5 ml pen injectors, with an ultimate completion date of July 28, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEHADDelivery Order
The Defense Logistics Agency awarded a $12,402.76 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Mounjaro 5 mg/0.5 ml pen injectors on September 2, 2025, with completion scheduled for September 3, 2025. This non-set-aside contract represents a small-value pharmaceutical supply order to be fulfilled at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026, serving as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, has demonstrated capability to meet federal procurement requirements through competitive award processes. The company supplies an extensive portfolio of pharmaceutical products and medical supplies to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This Mounjaro order is consistent with AmerisourceBergen's established role as a critical vendor within the DLA's medical supply chain, fulfilling ongoing pharmaceutical needs across multiple therapeutic domains for military and veteran healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.4k | 9/2/25 |